These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Follistatin-like 3 is a mediator of exercise-driven bone formation and strengthening. Nam J, Perera P, Gordon R, Jeong YH, Blazek AD, Kim DG, Tee BC, Sun Z, Eubank TD, Zhao Y, Lablebecioglu B, Liu S, Litsky A, Weisleder NL, Lee BS, Butterfield T, Schneyer AL, Agarwal S. Bone; 2015 Sep; 78():62-70. PubMed ID: 25937185 [Abstract] [Full Text] [Related]
25. Roles of activin family in pancreatic development and homeostasis. Wiater E, Vale W. Mol Cell Endocrinol; 2012 Aug 15; 359(1-2):23-9. PubMed ID: 22406274 [Abstract] [Full Text] [Related]
26. Placental expression of myostatin and follistatin-like-3 protein in a model of developmental programming. Peiris HN, Ponnampalam AP, Osepchook CC, Mitchell MD, Green MP. Am J Physiol Endocrinol Metab; 2010 Apr 15; 298(4):E854-61. PubMed ID: 20103742 [Abstract] [Full Text] [Related]
32. Preparation of monovalent follistatin-like 3-Fc-fusion protein and evaluation of its effects on muscle mass in mice. Ozawa T, Miyazono K, Morikawa M. STAR Protoc; 2021 Dec 17; 2(4):100839. PubMed ID: 34585166 [Abstract] [Full Text] [Related]
34. Systemic administration of monovalent follistatin-like 3-Fc-fusion protein increases muscle mass in mice. Ozawa T, Morikawa M, Morishita Y, Ogikubo K, Itoh F, Koinuma D, Nygren PÅ, Miyazono K. iScience; 2021 May 21; 24(5):102488. PubMed ID: 34113826 [Abstract] [Full Text] [Related]